Teen Depression Awareness Project (TDAP)

This study has been completed.
Information provided by:
ClinicalTrials.gov Identifier:
First received: December 21, 2004
Last updated: October 14, 2011
Last verified: October 2011
The main objective of this research project is to describe the impact of depression on adolescent and family functioning compared to that of healthy adolescents and to understand the impact of Feedback and Patient Activation (FPA) on teen and family decision-making regarding seeking care for depressive disorders.

Condition Intervention Phase
Behavioral: Education
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Teen Depression Awareness Project- This Project Examines the Services Used by Teens Identified in Primary Care Settings With Depression

Further study details as provided by RAND:

Primary Outcome Measures:
  • Receipt of Care [ Time Frame: September 30, 2007 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Journal Article [ Time Frame: September, 2007 ] [ Designated as safety issue: No ]
  • Journal Articles [ Time Frame: September, 2007 ] [ Designated as safety issue: No ]

Enrollment: 368
Study Start Date: October 2003
Study Completion Date: September 2006
Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Education
    Individuals will receive information about depression
  Show Detailed Description


Ages Eligible for Study:   13 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Between the ages of 13-17
  • Attending School
  • Living with parent or guardian
  • Reads and writes English
  • Receiving care at a participating PCP office

Exclusion Criteria:

  • Pregnancy
  • Parents don't speak English or Spanish
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00099827

United States, California
Family Care Specialists at White Memorial Medical Center
Los Angeles, California, United States, 90033
Northeast Valley Health Corporation-San Fernando Valley High School
San Fernando, California, United States, 91340
United States, District of Columbia
Children's National Medical Center Adolescent Health Clinic
Washington, District of Columbia, United States, 20010
Children's Pediatricians and Associates
Washington, District of Columbia, United States, 20037
United States, Maryland
Capital Medical Group
Chevy Chase, Maryland, United States, 20815
Kaiser Mid-Atlantic
Kensington, Maryland, United States, 20895
Kaiser Mid-Atlantic
Rockville, Maryland, United States, 20852
Kaiser Mid-Atlantic-Camp Springs
Temple Hills, Maryland, United States, 20748
Sponsors and Collaborators
Principal Investigator: Audrey Burnam, PhD RAND
  More Information

Additional Information:
Responsible Party: Audrey Burnam, RAND
ClinicalTrials.gov Identifier: NCT00099827     History of Changes
Other Study ID Numbers: TDAP2 
Study First Received: December 21, 2004
Last Updated: October 14, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by RAND:

Additional relevant MeSH terms:
Depressive Disorder
Behavioral Symptoms
Mental Disorders
Mood Disorders

ClinicalTrials.gov processed this record on May 04, 2016